The PE Ratio as of November 2024 (TTM) for Celldex Therapeutics, Inc. (CLDX) is -10.47

According to Celldex Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.47. This represents a change of -32.36% compared to the average of -15.48 of the last 4 quarters.

Celldex Therapeutics, Inc. (CLDX) Historical PE Ratio (quarterly & annually)

How has CLDX PE Ratio performed in the past?

The mean historical PE Ratio of Celldex Therapeutics, Inc. over the last ten years is -9.61. The current -10.47 PE Ratio has changed 10.79% with respect to the historical average. Over the past ten years (40 quarters), CLDX's PE Ratio was at its highest in in the March 2020 quarter at -0.57. The PE Ratio was at its lowest in in the September 2021 quarter at -29.99.

Celldex Therapeutics, Inc. (CLDX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Celldex Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Celldex Therapeutics, Inc. (CLDX) Average PE Ratio

How has CLDX PE Ratio performed in the past?

The current PE Ratio of Celldex Therapeutics, Inc. (CLDX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Celldex Therapeutics, Inc. (CLDX) PE Ratio vs. Peers

How is CLDX’s PE Ratio compared to its peers?

Celldex Therapeutics, Inc.’s PE Ratio is greater than IDEAYA Biosciences, Inc. (-12.96), less than AnaptysBio, Inc. (-3.88), less than MeiraGTx Holdings plc (-4.82), greater than Keros Therapeutics, Inc. (-11.12), less than Homology Medicines, Inc. (-0.01), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), greater than Avidity Biosciences, Inc. (-19.02), greater than Revolution Medicines, Inc. (-16.70), greater than Day One Biopharmaceuticals, Inc. (-15.73), greater than SpringWorks Therapeutics, Inc. (-10.53), less than Cytokinetics, Incorporated (-10.02), greater than DICE Therapeutics, Inc. (-22.94), greater than Edgewise Therapeutics, Inc. (-24.30), greater than Karuna Therapeutics, Inc. (-37.08), less than Dyne Therapeutics, Inc. (-10.17), greater than Crinetics Pharmaceuticals, Inc. (-16.16), less than ALX Oncology Holdings Inc. (-0.49), greater than Immatics N.V. (-12.59), less than BioAtla, Inc. (-0.93), less than Aerovate Therapeutics, Inc. (-0.91), less than Travere Therapeutics, Inc. (-4.04), less than Ventyx Biosciences, Inc. (-0.86), less than Cogent Biosciences, Inc. (-4.15),

Build a custom stock screener for Celldex Therapeutics, Inc. (CLDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celldex Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celldex Therapeutics, Inc. (CLDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celldex Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.